What is ASP7147 used for?

ASP7147 is indicated for Treatment of moderate to severe asthma.

ASP7147 is developed by Seldar Pharma, Inc..

What are the side effects of ASP7147?

Common side effects include Upper respiratory tract infection, Headache, Nausea, Diarrhea.

Last reviewed 2026-04-23 · How we verify

ASP7147

Seldar Pharma, Inc. · Phase 2 active Small molecule

ASP7147 is a small molecule inhibitor of the PI3K delta subunit.

ASP7147 is a small molecule inhibitor of the PI3K delta subunit. Used for Treatment of moderate to severe asthma.

At a glance

Generic name	ASP7147
Sponsor	Seldar Pharma, Inc.
Drug class	PI3K delta inhibitor
Target	PI3K delta
Modality	Small molecule
Therapeutic area	Immunology
Phase	Phase 2

Mechanism of action

By inhibiting the PI3K delta subunit, ASP7147 is thought to modulate immune cell function and potentially treat various inflammatory and autoimmune diseases.

Approved indications

Treatment of moderate to severe asthma

Common side effects

Upper respiratory tract infection
Headache
Nausea
Diarrhea

Key clinical trials

A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results